ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer

Yang, Liping; Chang, Jianfei; He, Xitao; Peng, Mengye; Zhang, Ying; Wu, Tingting; Xu, Panpan; Chu, Wenjie; Gao, Chao; Cao, Shaodong*; Kang, Shi*哈尔滨医科大学
Frontiers in Oncology2022-11-7DOI: 10.3389/fonc.2022.849626
4被引6阅读
引用收藏
分享

摘要

Background: The aim of this study was to evaluate the clinical usefulness of radiomics signature-derived F-18-fluorodeoxyglucose (F-18- FDG) positron emission tomography-computed tomography (PET-CT) for the early prediction of neoadjuvant chemotherapy (NAC) outcomes in patients with (BC). @@@ Methods: A total of 124 patients with BC who underwent pretreatment PET-CT scanning and received NAC between December 2016 and August 2019 were studied. The dataset was randomly assigned in a 7:3 ratio to either the training or validation cohort. Primary tumor segmentation was performed, and radiomics signatures were extracted from each PET-derived volume of interest (VOI) and CT-derived VOI. Radiomics signatures associated with pathological treatment response were selected from within a training cohort (n = 85), which were then applied to generate different classifiers to predict the probability of pathological complete response (pCR). Different models were then independently tested in the validation cohort (n = 39) regarding their accuracy, sensitivity, specificity, and area under the curve (AUC). @@@ Results: Thirty-five patients (28.2%) had pCR to NAC. Twelve features consisting of five PET-derived signatures, four CT-derived signatures, and three clinicopathological variables were candidates for the model's development. The random forest (RF), k-nearest neighbors (KNN), and decision tree (DT) classifiers were established, which could be utilized to predict pCR to NAC with AUC ranging from 0.819 to 0.849 in the validation cohort. @@@ Conclusions: The PET/CT-based radiomics analysis might provide efficient predictors of pCR in patients with BC, which could potentially be applied in clinical practice for individualized treatment strategy formulation.

学科与关键词

关键词
breast neoplasmsPositron Emission Tomography-Computed Tomographyneoadjuvant therapiespathological complete responseartificial intelligence
相关
加载中…
  • Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT
    Huang, Xiaomei; Mai, Jinhai; Huang, Yanqi; He, Lan; Chen, Xin; Wu, Xiaomei; Li, Yexing; Yang, Xiaojun; Dong, Mengyi; Huang, Jia; Zhang, Fang; Liang, Changhong*; Liu, Zaiyi*Clinical Breast Cancer, 2021, 21(4): E388-E401.被引 9
  • 18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer
    Zheng, Xingxing; Huang, Yuhong; Lin, Yingyi; Zhu, Teng; Zou, Jiachen; Wang, Shuxia*; Wang, Kun*EJNMMI Research, 2023, 13(1): 105.
  • Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer
    Zeng, Qiao; Xiong, Fei; Liu, Lan; Zhong, Linhua; Cai, Fengqin; Zeng, Xianjun*ACADEMIC RADIOLOGY, 2023, 30 Suppl 2: S38-S49.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-11-07
卷期
第 12 卷
页码
849626
DOI
10.3389/fonc.2022.849626
期刊等级
3区
成果收录
SCIE
资助标注
Haiyan Funding of Harbin Medical University Cancer Hospital; [JJQN2019-23]

作者

  • Y

    Yang, Liping (第一作者)

    harbin med univ

  • C

    Chang, Jianfei

    new

查看全部 11 位作者收起作者
  • H

    He, Xitao

  • P

    Peng, Mengye

    harbin med univ

  • Z

    Zhang, Ying

    harbin med univ

  • W

    Wu, Tingting

    harbin med univ

  • X

    Xu, Panpan

    harbin med univ

  • C

    Chu, Wenjie

    harbin med univ

  • G

    Gao, Chao

    harbin med univ

  • C

    Cao, Shaodong (通讯)

    harbin med univ

  • K

    Kang, Shi (通讯)

    hosp heilongjiang prov

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417